Uncategorized

By: Clinical Trial Partnerships If you are planning clinical trials, Pride Month is the perfect time to take a close look at your diversity initiatives to be sure they encompass inclusion of LGBTQ+ patients in clinical trials. This is an important goal that carries unique challenges. Recent studies reveal that LGBTQ+ community members experience healthcare…

By: Clinical Partnerships Team It’s no secret that patient recruitment is critical for a successful clinical trial. From first patient/first dose to data lock, everything rests on enrolling (and retaining) enough participants. Otherwise, costs go up, and so does demand on resources. Treatments take longer to get to market or—worse yet—the trial gets cancelled. But…

By: Reverba Clinical Partnerships Team From first patient/first dose to data lock, everything depends on recruiting and retaining clinical trial participants. That can be quite challenging. A 2022 editorial in Clinical Trials Arena noted that the biggest reason for trial termination is low accrual rates which have accounted for 25.4% of all terminated trials. The good…

Today is Clinical Trials Day –a day where clinical trial awareness is raised and we honor clinical research professionals across the globe. In tribute, we are pleased to showcase a recent article in MedCityNews where a Health Stories Project® research study was cited, revealing that 97% of patients believe that their voice is key for…

By:  Jean McCoy EVP  Reverba Partnerships When it comes to listening to patients, clinical and consumer marketing tends to remain in separate silos. But incorporating the patient voice can make a positive impact at every point from pre-clinical development through commercialization and post-marketing. Doing so can help companies align their goals and programs with patients’…